Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
1(11%)
Results Posted
125%(5 trials)
Terminated
2(22%)

Phase Distribution

Ph phase_3
2
22%
Ph phase_4
2
22%
Ph early_phase_1
1
11%
Ph phase_2
2
22%
Ph phase_1
1
11%

Phase Distribution

2

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(4)
Terminated(3)

Detailed Status

Completed4
Terminated2
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (12.5%)
Phase 11 (12.5%)
Phase 22 (25.0%)
Phase 32 (25.0%)
Phase 42 (25.0%)

Trials by Status

active_not_recruiting111%
terminated222%
completed444%
not_yet_recruiting111%
withdrawn111%

Recent Activity

1 active trials
Showing 5 of 9
terminatedphase_4

Study on Allopregnanolone and Depression in Perimenopausal Women

NCT05329779
active_not_recruitingphase_1

Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder

NCT05223829
completedphase_2

An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus

NCT05645432
completedphase_3

A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)

NCT03665038
not_yet_recruitingphase_2

Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study

NCT06580444
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05329779Phase 4

Study on Allopregnanolone and Depression in Perimenopausal Women

Terminated
NCT05223829Phase 1

Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder

Active Not Recruiting
NCT05645432Phase 2

An Open-Label Study Evaluating Brexanolone in Adults With Tinnitus

Completed
NCT03665038Phase 3

A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)

Completed
NCT06580444Phase 2

Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study

Not Yet Recruiting
NCT05543746

Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum Depression

Completed
NCT05314153Early Phase 1

Effects Zulresso on Postpartum Psychosis

Completed
NCT04537806Phase 3

A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)

Terminated
NCT04273191Phase 4

A Study to Evaluate Multimodal Neuroimaging Parameters in Women With Postpartum Depression Who Are Receiving ZULRESSO™ (Brexanolone)

Withdrawn

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9